# Tofacitinib for Inflammatory Eye Disease

> **NCT03580343** · PHASE2 · UNKNOWN · sponsor: **Washington University School of Medicine** · enrollment: 5 (actual)

## Conditions studied

- Uveitis
- Scleritis

## Interventions

- **DRUG:** tofacitinib

## Key facts

- **NCT ID:** NCT03580343
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-04
- **Primary completion:** 2019-12-01
- **Final completion:** 2021-04-04
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2021-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03580343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03580343, "Tofacitinib for Inflammatory Eye Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03580343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*